BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11550317)

  • 21. Correlation of ganglioside patterns of primary brain tumors with survival.
    Sung CC; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Zheng M; Yates AJ
    Cancer; 1995 Feb; 75(3):851-9. PubMed ID: 7828137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutral glycolipid composition of primary human brain tumors.
    Singh LP; Pearl DK; Franklin TK; Spring PM; Scheithauer BW; Coons SW; Johnson PC; Pfeiffer SE; Li J; Knott JC
    Mol Chem Neuropathol; 1994; 21(2-3):241-57. PubMed ID: 8086036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas.
    Jensen SS; Aaberg-Jessen C; Christensen KG; Kristensen B
    Int J Clin Exp Pathol; 2013; 6(7):1294-305. PubMed ID: 23826410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors affecting the prognosis of brain tumors].
    Yoshimine T; Hayakawa T; Mogami H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
    Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
    In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 immunohistochemical positivity as a prognostic marker in intracranial tumours.
    Soini Y; Niemelä A; Kamel D; Herva R; Bloigu R; Pääkkö P; Vähäkangas K
    APMIS; 1994 Oct; 102(10):786-92. PubMed ID: 7826609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors.
    Demeule M; Shedid D; Beaulieu E; Del Maestro RF; Moghrabi A; Ghosn PB; Moumdjian R; Berthelet F; Béliveau R
    Int J Cancer; 2001 Jul; 93(1):62-6. PubMed ID: 11391622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
    Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
    APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
    Gunal A; Onguru O; Safali M; Beyzadeoglu M
    Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
    Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycolipid markers of astrocytomas and oligodendrogliomas.
    Yates AJ; Comas T; Scheithauer BW; Burger PC; Pearl DK
    J Neuropathol Exp Neurol; 1999 Dec; 58(12):1250-62. PubMed ID: 10604750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading.
    Wagener R; Röhn G; Schillinger G; Schröder R; Kobbe B; Ernestus RI
    Acta Neurochir (Wien); 1999; 141(12):1339-45. PubMed ID: 10672306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvessel density is a prognostic indicator for patients with astroglial brain tumors.
    Leon SP; Folkerth RD; Black PM
    Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic analysis to complement histopathological diagnosis of brain tumors.
    Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
    Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
    Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
    Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.